Correlation Between Virax Biolabs and Inotiv
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Inotiv at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Inotiv into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Inotiv Inc, you can compare the effects of market volatilities on Virax Biolabs and Inotiv and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Inotiv. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Inotiv.
Diversification Opportunities for Virax Biolabs and Inotiv
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Virax and Inotiv is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Inotiv Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inotiv Inc and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Inotiv. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inotiv Inc has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Inotiv go up and down completely randomly.
Pair Corralation between Virax Biolabs and Inotiv
Given the investment horizon of 90 days Virax Biolabs Group is expected to under-perform the Inotiv. But the stock apears to be less risky and, when comparing its historical volatility, Virax Biolabs Group is 1.2 times less risky than Inotiv. The stock trades about -0.14 of its potential returns per unit of risk. The Inotiv Inc is currently generating about 0.43 of returns per unit of risk over similar time horizon. If you would invest 168.00 in Inotiv Inc on August 24, 2024 and sell it today you would earn a total of 173.00 from holding Inotiv Inc or generate 102.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Inotiv Inc
Performance |
| Timeline |
| Virax Biolabs Group |
| Inotiv Inc |
Virax Biolabs and Inotiv Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Inotiv
The main advantage of trading using opposite Virax Biolabs and Inotiv positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Inotiv can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inotiv will offset losses from the drop in Inotiv's long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance |